It's a Bear Market, but Is This Stock in Even More Trouble?

This isn't news to anyone, but the market has been struggling all year. Indeed, the S&P 500 is in bear market territory, defined as a 20% (or more) drop from its most recent high. But some stocks are performing even worse.

Take biotech company Novavax (NASDAQ: NVAX). This vaccine maker is down by 64% since the beginning of the year. While the broader market sell-off hasn't helped Novavax, the company has encountered its own issues, too. Should investors give up on Novavax?

Continue reading

Source Fool.com